A Prospective Phase III Study of Patients with Newly Diagnosed Very Low-risk and Low-risk Fusion Negative Rhabdomyosarcoma

Brief Summary

Type:
Sarcomas

Study Type:
Treatment

Phase:
III

ClinicalTrials.gov Identifier:
NCT05304585

Study #:
CMH - ARST2032

Start Date:
Aug 22, 2022

Full Details and Eligibility at clinicaltrials.gov

By taking part in a clinical trial, you have access to potentially effective treatments not available elsewhere. Additionally, you will contribute to cancer research, which can help other cancer patients in the future. Read the full details of this specific clinical trial by clicking on the link below.

ClinicalTrials.gov ID: NCT05304585

View Complete Trial Details & Eligibility at ClinicalTrials.gov